EODData

MEMBERSHIP REGISTER LOG IN

FRA, 0VY: I-MAB SPONS.ADS/1 -0001

14 Jul 2026
LAST:

1.610

CHANGE:
 0.02		OPEN:
1.610		HIGH:
1.610		ASK:
0.000		VOLUME:
0
CHG(%):
1.23		PREV:
1.630		LOW:
1.610		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
14 Jul 261.6101.6101.6101.6100
13 Jul 261.6301.6301.6301.6300
10 Jul 261.6101.6101.6101.6100
09 Jul 261.6601.6601.6601.6600
08 Jul 261.7401.7401.7401.7400
07 Jul 261.7201.7201.7201.7200
06 Jul 261.8901.8901.8901.8900
03 Jul 261.8401.8401.8401.8400
02 Jul 261.7301.7301.7301.7301.0K
30 Jun 261.7101.7101.7101.7100

PROFILE

Name:I-MAB SPONS.ADS/1 -0001
About:I-Mab, a biotech company, focuses on the development of immuno-oncology agents for the treatment of cancer in the United States. The company is developing givastomig, a bispecific antibody, which is in Phase 1b clinical trial for the treatment of gastric cancer; uliledlimab, a CD73 neutralizing antibody; and ragistomig, a bispecific antibody, which is in phase 1 clinical trial for the treatment of solid tumors. It has a strategic licensing agreement with Ferring International Center SA to research, develop, make, have made, import, use, sell, and offer to sell FE301, an interleukin-6 inhibitor. The company also has collaborations with Bristol Myers Squibb for the development of givastomig; ABL Bio, Inc. for the development of givastomig and ragistomig; and TJ Bio for the development of uliledlimab. I-Mab was founded in 2014 and is headquartered in Rockville, Maryland.
Sector:Healthcare
Industry:Biotechnology
Address:2440 Research Boulevard, Rockville, MD, United States, 20850
Website:https://www.i-mabbiopharma.com
ISIN:US44975P1030
LEI:549300L1A5T19703RR64

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-14.78 
Forward P/E:-2.86 
PEG Ratio:0.12 
Price to Sales:24.78 
Price to Book:1.75 
Return on Assets:-0.10 
Return on Equity:-0.18 
Revenue:569.5K 
Shares:81.66M 
Market Cap:131.47M 

TECHNICAL INDICATORS

MA5:1.652.5%
MA10:1.716.5%
MA20:1.525.9%
MA50:1.572.8%
MA100:1.9822.7%
MA200:2.7470.4%
STO14:51.72
RSI14:65.26 
WPR14:-48.28
MTM14:0.30
ROC14:0.23 
ATR:0.07 
Week High:1.748.1%
Week Low:1.610.0%
Month High:1.8917.4%
Month Low:1.2570.4%
Year High:5.60247.8%
Year Low:1.2528.8%